The Claim
Intravenous lysine infusion in healthy children is associated with elevated plasma ornithine and urinary putrescine levels, suggesting impaired mitochondrial ornithine transport.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When healthy children receive lysine through an IV, their blood ornithine and urine putrescine levels rise, indicating a reduction in the ability of mitochondria to transport ornithine.
See the scientific wording
Intravenous lysine infusion in healthy children is associated with elevated plasma ornithine and urinary putrescine, suggesting impaired mitochondrial ornithine transport.
When lysine enters liver cells, it blocks the transport of ornithine into the energy-producing parts of the cell, so ornithine builds up in the blood. The excess ornithine gets converted into putrescine in other parts of the cell and is dumped into urine. At the same time, lysine also stops a key enzyme from using ornithine to make urea, which causes more ornithine to pile up and triggers the production of abnormal waste products.
What the research says
1 studyStudy: Inhibitory effect of intravenous lysine infusion on urea cycle metabolism
When kids got a special IV drip of lysine, their blood had more ornithine and their pee had more putrescine, which means their cells couldn’t move ornithine into the energy factories (mitochondria) properly. The study saw exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.